016580.KS
Whan In Pharm Co.,Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 10,390.00
−0.48%Margins
Gross margin
45.8%
EBITDA margin
10.9%
EBIT margin
8.2%
Net margin
7.5%
FCF margin
5.5%
4.8%
Return on equity
4.2%
Return on assets
5.2%
Return on invested capital
0.57x
Asset turnover
KRW 17.7B
Cash from operations
KRW 3.6K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026